Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

NCT04804813 · clinicaltrials.gov ↗
COMPLETED
Status
388
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda